(Q42182730)

18 October 2017

0 references

Cataract Surgery in Behçet's Disease Patients One Week after Infliximab Administration (English)

1 reference

18 October 2017

0 references

Tsuneaki Handa

1

1 reference

PMCID

3124453

18 October 2017

Hinako Tsunekawa

series ordinal

2

1 reference

PMCID

3124453

18 October 2017

Masahiro Zako

series ordinal

3

1 reference

18 October 2017

24 May 2011

1 reference

Case Reports in Ophthalmology

18 October 2017

1 reference

18 October 2017

2

1 reference

18 October 2017

2

1 reference

18 October 2017

176-178

1 reference

Infections and anti–tumor necrosis factor α therapy

18 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124453

Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124453

Relationship between serum infliximab levels and acute uveitis attacks in patients with Behcet disease

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124453

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124453

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3124453

Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs

17 August 2018

1 reference

12 December 2020

Intraocular surgery in patients receiving infliximab therapy for Behçet disease

1 reference

12 December 2020

Cataract surgery under infliximab therapy in a patient with Behçet's disease

1 reference

12 December 2020

Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies

1 reference

12 December 2020

Efficient penetration into aqueous humor by administration of oral and topical levofloxacin

1 reference

12 December 2020

Identifiers

DOI

10.1159/000329091

1 reference

18 October 2017

1 reference

18 October 2017

1 reference

PMCID

3124453